IPTp-SP arm (N = 342)a | N | n | Intermediate process effectiveness, % (95% CI) | Cumulative delivery effectiveness % |
---|---|---|---|---|
DOT | ||||
 1. 2nd or 3rd trimesterb | 342 | 336 | 100 |  |
 2. Given any SPc | 319 | 239 | 74.9 (54.8,88.0) | 74.9 |
 3. Given dose of 3 tablets | 239 | 237 | 100 | 74.9 |
 4. Took dose by DOT | 237 | 179 | 75.5 (31.7,95.4) | 56.5 |
With or without DOT | ||||
 1. Given any SP | 319 | 239 | 74.9 (54.8,88.0) | 74.9 |
 2. Given dose of 3 tabletsd | 239 | 237 | 100 | 74.9 |
 3a. Took dose by DOT | 237 | 179 | 75.5 (31.7,95.4) | 56.5 |
 3b. SP not given by DOT | 237 | 58 | 24.5 (4.6,68.3) | 24.5 |
 4. Has SP on exit | 58 | 2 | 3.4 (0.2,38.0) | 3.4 |
 5. Knows how to take 3 tablets SPe | 2 | 1 | 100.0 (0,100) | 3.4 |
 6. Composite endpoint | 336 | 180 |  | 53.6 |